English-language podcasts

The Line

How Canada will fight, and who we'll let in

53 min

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

In this episode of On The Line, host Matt Gurney is joined by two guests to discuss what the federal budget tells us about Canada's plans for national defence, immigration, housing and the economy. This episode is brought to you by BioCanRx. This week we asked whether the new federal budget improves the landscape for Canadian drug development. Short answer: it does! New tax incentives will support Canadian biotech companies carrying out commercialization and regulatory activities in Canada, and federal research funding agencies will modernize to offer additional support for bridging lab to market. The government also pledged to respond to recommendations from last summer’s Pharmaceutical and Life Sciences Sector Task Force. Steps like these can address key challenges facing Canada's life-sciences sector and make Canada more globally competitive. There is much more work to do to support Canadian health-care systems. BioCanRx will continue to participate in any effort to strengthen Canada's life-sciences ecosystem and help Canadian discoveries become therapies to treat patients across Canada and the world. Thanks to them for continuing to partner with The Line to share this information. VisitBioCanRx.com (http://biocanrx.com/) to learn more. First up is Philippe Lagassé, a defence expert at Carleton University, who joins Matt to examine the budget's national security commitments. How much is Canada actually spending on defence, and how sustainable is that spending? Lagassé explains why the government's plans may be more financially realistic than previously thought, provided spending stays within certain limits. But unexpected events have a way of disrupting even the best-laid plans, especially in an increasingly dangerous world. Matt and Phil also discuss the proposed funding increase for Canadian intelligence agencies. What problems is the government trying to solve, and what capabilities does Canada need to develop? And, finally, a question for the military procurement enthusiasts: are we actually going to get a Canadian MI6? The episode is also brought to you by the Forest Products Association of Canada. Now, we need to move from promises to production. Canada’s forest sector is ready to do its part. Learn more atFPAC.ca (http://fpac.ca/). Then Matt is joined by economist Mike Moffatt of the Missing Middle Initiative to discuss some surprising immigration numbers buried in the budget. There's the official immigration target, and then there's what amounts to a second, much larger shadow target. Why is the government planning for so many more people than the headline numbers suggest? Moffatt explains that there's a legitimate policy rationale behind the approach, but also a much more troubling problem: Canada has built structural dependencies into its immigration system that are increasingly difficult to unwind without making those arrangements permanent. Matt and Mike discuss the risks of continuing without a coherent long-term strategy, and why Canada urgently needs to think beyond annual immigration targets and start planning for the country it actually intends to build. This episode is also brought to you by Cameco. Check out our main page at ReadTheLine.ca. Like and subscribe! #OnTheLine #CanadaPolitics #Budget2026 #CanadianMilitary #DefenceSpending #NationalSecurity #CanadianIntelligence #Immigration #ImmigrationPolicy #HousingCrisis #PhilippeLagasse #MikeMoffatt #MattGurney

Episode information is provided by the publisher. Listening takes place on the publisher’s service.

Listen at the source ↗

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

More from The Line

The Line

Carney sticks it to Putin ... but will food prices sink him?

69 min

In this episode of On The Line, host Matt Gurney is joined by two guests to discuss hockey, inflation, politics, and whether Canada can finally get serious about building major infrastructure. This episode is brought to you by BioCanRx. This month we’re addressing common questions, like: do these therapies have export potential? The farthest advanced BioCanRx-supported therapies are still in clinical trials here in Canada, but other countries are already expressing interest based on their efficacy and lower cost. Canadian-developed CAR-T technology from the CLIC group is already being used to treat clinical trial patients in Denmark, and other countries with high numbers of leukemia cases have expressed interest. A successful clinical trial in another country can be an important first step toward bringing that therapy to market there. If BioCanRx-supported therapies continue to be trialed outside Canada, it sends a strong signal that made-in-Canada immunotherapies will find a receptive

Discuss this episode

The Line

Carney's Immigration Fail

67 min

In the latest episode of The Line Podcast, recorded on November 13th, 2026, Matt Gurney is joined by Andrew Potter, filling in for Jen Gerson from Montreal. This episode is brought to you by Cameco. First up, your hosts tackle the immigration debate now exploding across Canada. Both are very mindful of the fact that they're middle-aged white dudes, but they have serious concerns about the government's new proposals. For one thing, the economic rationale simply isn't there. For another, the Liberals have done almost none of the political groundwork necessary to sell these changes to Canadians. As Andrew notes, this government, like most Liberal governments, hates having to explain itself to the public. Matt worries that the consequences could be severe. Canada has maintained a remarkable pro-immigrant consensus for decades, and while Canadians have clearly soured on immigration, they haven't yet soured on immigrants. That distinction matters. And it might not last. Next, Matt and Andrew

Discuss this episode

The Line

Conservatives can't cope with Carney's wins

79 min

In the latest episode of The Line Podcast, recorded between November 5th and 6th, 2026, Matt Gurney and Jen Gerson are joined by special guest Stephanie Levitz of The Globe and Mail. This episode is also brought to you by Cameco. First up, a brief explainer: due to Jen's being at a conference, part of this episode was recorded earlier in the week, after the midterms, but before the Canadian federal budget had been released. To avoid ignoring one of the huge stories of the week, Matt recorded a special segment of the podcast on Friday, after Jen had left for her event. In that segment, Stephanie Levitz joins Matt for a quick discussion of the federal budget. What's in it, what's missing, and what does it tell us about the Carney government's priorities? They take stock of what Ottawa is promising, what it's actually prepared to spend money on, and what Canadians should take away from it all. This episode is also brought to you by BioCanRx. This month we’re addressing common questions, l

Discuss this episode

Community Poll

Publicly funded stadiums should provide clear, measurable benefits to local residents.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

A disgraced billionaire's name is on the beloved campus library. Does it come down?

A major donor funded a beloved public building decades ago. New evidence shows they also caused serious harm that was legal and accepted by many peers at the time. Removing the name may jeopardize future donations.

What does an institution owe the truth when its history funded the present?

Explore this quandary